Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1330 issues

Get Orladeyo (Berotralstat) Covered by Blue Cross Blue Shield in Pennsylvania: Complete Prior Authorization Guide with Appeals Process

Answer Box: Getting Orladeyo Covered by Blue Cross Blue Shield in Pennsylvania Fastest Path to Approval: Orladeyo requires prior authorization from all Pennsylvania Blue Cross Blue Shield plans. You'll need documented HAE diagnosis with C1-INH testing, evidence of failed injectable prophylaxis (Takhzyro, Haegarda, or Cinryze), and HAE specialist

Renewing Upstaza (Kebilidi) Approval with Blue Cross Blue Shield of Texas: 2025 Requirements & Timeline

Answer Box: Upstaza (Kebilidi) gene therapy for AADC deficiency requires annual prior authorization renewal with Blue Cross Blue Shield of Texas 30-60 days before expiration. Start 90 days early to prevent coverage gaps. Required documents include clinical assessments, motor milestone evaluations, and 12-month outcome data. Submit through Availity Authorization &

How to Get Firdapse (Amifampridine) Covered by Blue Cross Blue Shield in New York: Forms, Appeals, and Success Strategies

Answer Box: Getting Firdapse Covered in New York Eligibility: Firdapse (amifampridine) requires prior authorization from Blue Cross Blue Shield plans in New York for patients with confirmed Lambert-Eaton myasthenic syndrome (LEMS). Fastest Path: Contact your BCBS member services to obtain the current prior authorization form, have your neurologist complete clinical

How to Get Zanzalintinib (XL092) Covered by Blue Cross Blue Shield in Virginia: Clinical Trial Access and Compassionate Use Guide

Answer Box: Getting Zanzalintinib (XL092) Coverage in Virginia Zanzalintinib (XL092) is not FDA-approved and typically isn't covered by Blue Cross Blue Shield Virginia outside clinical trials. Your fastest path: 1) Check ClinicalTrials.gov for ongoing STELLAR program studies, 2) Contact Exelixis directly about compassionate use programs, and 3)

The Complete Requirements Checklist to Get Strensiq (Asfotase Alfa) Covered by Blue Cross Blue Shield in Virginia

Answer Box: Your Path to Strensiq Coverage in Virginia Getting Strensiq (asfotase alfa) covered by Blue Cross Blue Shield in Virginia requires prior authorization with genetic or biochemical confirmation of pediatric-onset hypophosphatasia. The fastest path: have your doctor submit genetic testing (ALPL mutation) or low alkaline phosphatase levels plus elevated

Getting Blenrep (Belantamab Mafodotin) Covered by Blue Cross Blue Shield in Ohio: Current Access Options and Appeals Process

Answer Box: Your Fastest Path to Blenrep Access in Ohio Current Status: Blenrep is not commercially available but accessible through GSK's compassionate use program. Blue Cross Blue Shield in Ohio requires prior authorization for specialty drugs, with standard review taking 5-15 business days. Since Blenrep remains under FDA

How to Get Natpara (Parathyroid Hormone) Covered by Blue Cross Blue Shield in Pennsylvania: Appeals Guide with Forms and Timelines

Answer Box: Getting Natpara Covered in Pennsylvania Important Update: Takeda discontinued Natpara manufacturing globally, with the U.S. Special Use Program ending December 31, 2025. New prescriptions are typically denied due to lack of commercial supply. For existing patients transitioning off Natpara, Pennsylvania's external review program offers strong

How to Get Tremfya (Guselkumab) Covered by Blue Cross Blue Shield of Illinois: 2025 Appeal Guide with Forms and Timelines

Answer Box: Getting Tremfya Covered by BCBS Illinois Fastest path to approval: Submit prior authorization through CoverMyMeds or fax to 1-800-693-6703 with complete clinical documentation. If denied, you have strong appeal rights under Illinois law—including a ban on step therapy and binding external review within 30 days. Start today:

Work With Your Doctor to Get Tegsedi (inotersen) Covered by Blue Cross Blue Shield in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tegsedi Covered by Blue Cross Blue Shield in New York Eligibility: Tegsedi (inotersen) requires prior authorization from Blue Cross Blue Shield for hATTR polyneuropathy in adults. You must be enrolled in the REMS program with regular lab monitoring. Fastest Path: Work with your neurologist to submit complete

Myths vs. Facts: Getting Rebif (interferon beta-1a) Covered by Blue Cross Blue Shield in North Carolina

Answer Box: Getting Rebif Covered by Blue Cross Blue Shield in North Carolina Eligibility: Adults with relapsing forms of MS (CIS, RRMS, active SPMS) prescribed by a neurologist. Fastest path: Submit complete prior authorization with MRI evidence, documented relapses, and failed therapy history. First step today: Call Blue Cross NC